Margaret D. Bourlon

Engineering of OHet72 Nanocrystals into Nanostructured Microparticles for Pulmonary Delivery of a Novel Antitubercular Drug Candidate

Background/Objectives: Current treatments for tuberculosis (TB) are complex and associated with severe side effects; thus, drugs with minimal side effects would be desirable as additions to current therapies to combat the global TB epidemic. OHet72 is a novel compound with in vit...